Exopharm (AU: EX1)

Last close As at 21/11/2024

0.17

0.02 (10.00%)

Market capitalisation

26m

Edison Investment Research is terminating coverage on Exopharm. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

Healthcare | edison tv

Exopharm – Edison Open House interview

Healthcare | Initiation

Exopharm — All the parts for drug delivery development

Share Price Performance

Financials

Edison Investment Research is terminating coverage on Exopharm. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free